Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
- PMID: 11232002
- DOI: 10.1210/jcem.86.1.7131
Phenotype-genotype correlation in 56 women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Abstract
Complete analysis of the CYP21 gene was performed in 56 unrelated French women with symptomatic nonclassical congenital adrenal hyperplasia. The mutational spectrum and the phenotype-genotype correlation were examined. The overall predominant mutation was V281L, which was present on 51% of alleles and in 80% of women. Three novel mutations were found: L317M, R435C, and a 5'-end gene conversion. Sixty-three percent of the women were carrying a severe mutation of the CYP21 gene, and hence risk giving birth to children with a classical form of the disease. In such cases, screening for heterozygosity in the partner is crucial. Potential genotype/phenotype correlations were examined by classifying the patients into three groups according to the CYP21 allelic combinations: A (mild/mild), B (mild/severe), and C (severe/severe). Primary amenorrhea was more frequent, and mean basal and stimulated 17-hydroxyprogesterone levels were higher in compound heterozygotes for mild and severe mutations (group B) compared with women with two mild mutations (group A), but there was a considerable overlap for individual values. Surprisingly, in two women, a severe mutation was found on both alleles (group C). Therefore, the phenotype cannot be accurately predicted from the genotype. Variability in phenotypic expression may be conditioned by mechanisms other than genetic heterogeneity at the CYP21 locus.
Similar articles
-
A multicenter study of women with nonclassical congenital adrenal hyperplasia: relationship between genotype and phenotype.Mol Genet Metab. 2000 Nov;71(3):527-34. doi: 10.1006/mgme.2000.3036. Mol Genet Metab. 2000. PMID: 11073721
-
Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members.J Clin Endocrinol Metab. 2009 May;94(5):1570-8. doi: 10.1210/jc.2008-1582. Epub 2009 Feb 10. J Clin Endocrinol Metab. 2009. PMID: 19208730
-
Hyperandrogenism in carriers of CYP21 mutations: the role of genotype.Clin Endocrinol (Oxf). 2006 Jun;64(6):645-51. doi: 10.1111/j.1365-2265.2006.02521.x. Clin Endocrinol (Oxf). 2006. PMID: 16712666
-
Mutations in steroid 21-hydroxylase (CYP21).Hum Mutat. 1994;3(4):373-8. doi: 10.1002/humu.1380030408. Hum Mutat. 1994. PMID: 8081391 Review.
-
Congenital adrenal hyperplasia: phenotype and genotype.J Pediatr Endocrinol Metab. 2002 Dec;15 Suppl 5:1329-40. J Pediatr Endocrinol Metab. 2002. PMID: 12510987 Review.
Cited by
-
Recommendations for treatment of nonclassic congenital adrenal hyperplasia (NCCAH): an update.Steroids. 2012 Mar 10;77(4):342-6. doi: 10.1016/j.steroids.2011.12.009. Epub 2011 Dec 13. Steroids. 2012. PMID: 22186144 Free PMC article. Review.
-
Structural and functional analysis of a novel mutation of CYP21B in a heterozygote carrier of 21-hydroxylase deficiency.Hum Genet. 2005 Oct;117(6):558-64. doi: 10.1007/s00439-005-1339-3. Epub 2005 Jul 19. Hum Genet. 2005. PMID: 16028060
-
Congenital adrenal hyperplasia: diagnostic advances.J Inherit Metab Dis. 2007 Aug;30(4):563-75. doi: 10.1007/s10545-007-0696-6. Epub 2007 Aug 10. J Inherit Metab Dis. 2007. PMID: 17694353
-
Congenital Adrenal Hyperplasia.J Pediatr Adolesc Gynecol. 2017 Oct;30(5):520-534. doi: 10.1016/j.jpag.2017.04.001. Epub 2017 Apr 24. J Pediatr Adolesc Gynecol. 2017. PMID: 28450075 Free PMC article. Review.
-
Nonclassic congenital adrenal hyperplasia misdiagnosed as Turner syndrome.J Hum Reprod Sci. 2015 Oct-Dec;8(4):239-41. doi: 10.4103/0974-1208.170416. J Hum Reprod Sci. 2015. PMID: 26751945 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases